Alumni raised $1.45B in 2022 - Download Free Report Now

TranS1

Least invasive approach for the delivery of lumbar fusion and motion preservation therapies.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of TranS1 plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About TranS1

Technology/product details

CEO presentation

Competing Startups

More

Companies We Work With